News
POLB 001 has been granted FDA orphan drug designation as a preventative therapy for cytokine release syndrome caused by ...
Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ...
The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...
Those with ALS have an average survival of around two to five years from diagnosis, with most ALS patients dying from ...
Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that ...
Glenmark Pharmaceuticals seeks licensing deal for ISB 2001 drug candidate, plans growth with semaglutide in India.
Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...
European Commission grants orphan drug designation to Alligator Bioscience’s HLX22 to treat gastric cancer: Lund, Sweden Tuesday, May 27, 2025, 18:00 Hrs [IST] Alligator Bioscie ...
U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...
8d
News Medical on MSNAllopurinol, designated as first orphan drug for Marfan syndrome treatment in new researchThe European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results